SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001005794-02-000174
Filing Date
2002-11-13
Accepted
2002-11-13 17:27:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDED STATEMENT OF BENEFICIAL OWNERSHIP s13da110602.txt SC 13D/A 115546
  Complete submission text file 0001005794-02-000174.txt   117399
Mailing Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080 6506262200
CELLEGY PHARMACEUTICALS INC (Subject) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-45279 | Film No.: 02821033
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 340 EDGEMONT AVE SUITE 500 BRISTOL TN 37620 4239897211
GREGORY JOHN M (Filed by) CIK: 0001200376 (see all company filings)